2026-01-02 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the provided data, broken down into sections as requested.

**1) Return Rate Comparison:**

*   **Ticker:** PG (Procter & Gamble Co)
*   **Overview:** Procter & Gamble Co is a multinational consumer goods corporation that manufactures and markets a wide range of branded consumer products.
*   **PG Cumulative Return:** 20.02%
*   **S&P 500 (VOO) Cumulative Return:** 105.07%
*   **Divergence:** -85.06 (max: 15.2, min: -89.1, current: -85.1, relative divergence: 3.8)

**Analysis:** P&G has significantly underperformed the S&P 500 over the tracked period.  The divergence is large and negative, indicating a substantial lag in returns. The relative divergence of 3.8 suggests that this underperformance is near its worst levels within the historical range considered (almost bottom percentile position).
* **Alpha, Beta analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 13.0% | 66.9% | -17.0% | 0.5 | 215.1 |
| 2017-2019  | 43.0% | 70.1% | 1.0% | 0.5 | 292.3 |
| 2018-2020  | 61.0% | 78.6% | 28.0% | 0.7 | 325.7 |
| 2019-2021  | 70.0% | 78.6% | -6.0% | 0.7 | 382.9 |
| 2020-2022  | 22.0% | 79.3% | 3.0% | 0.6 | 354.7 |
| 2021-2023  | 14.0% | 80.5% | -14.0% | 0.4 | 343.0 |
| 2022-2024  | 4.0% | 80.5% | -26.0% | 0.4 | 392.4 |
| 2023-2025  | 1.0% | 80.3% | -67.0% | 0.2 | 335.4 |

**Analysis:** P&G's Beta values consistently remain below 1. This indicates that PG's stock price is generally less volatile than the overall market. Alpha values fluctuates. Overall, the trend shows a decline in both CAGR and Alpha, along with a decrease in Beta values, which may require careful monitoring.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 143.31
*   **Last Market Data:** Price: 143.31, Previous Close: 144.05, Change: -0.51
*   **5-day SMA:** 144.23
*   **20-day SMA:** 143.60
*   **60-day SMA:** 147.15

**Analysis:** The stock is currently trading below its 5-day and 60-day moving averages, but around its 20-day SMA. This suggests short-term weakness. The small negative change in the last market (-0.51) doesn't indicate a large fluctuation issue at this immediate moment.

**3) Technical Indicators and Signals:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 60.52
*   **PPO:** 0.13
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.7 (+) indicating a short-term increase
*   **Expected Return (%):** 0.0 (Neutral)

**Analysis:**

*   **MRI:** The high MRI suggests that the overall market conditions are favorable for investment.
*   **RSI:** An RSI of 60.52 is near the overbought threshold, but does not meet it.
*   **PPO:** The PPO is a small positive value, indicating that the short-term moving average is slightly above the long-term moving average.
*   **Hybrid Signal:** The signal recommends a fully invested position, emphasizing safety.
*   **Relative Divergence Change:** Recent uptick suggests a potential for near term outperformance versus the S&P500, after a long term underperformance.
*   **Expected Return:** The 0.0% expected return suggests no expectation to outperform the S&P500

**4) Recent News & Significant Events:**

*   **Positive Mentions:** Jim Cramer's favorable comments on PG ("Patience Is Going to Pay off") and identification as a favorite portfolio stock suggest positive sentiment from some analysts.
*   **Analyst Opinions:** "Buy PG Stock Over Colgate-Palmolive?" suggesting PG is favorable to peer companies
*   **Negative Signals:** "Why Procter & Gamble Stock Hit a 2-Year Low on Tuesday" indicates some recent struggles.
*   **Institutional Activity:** "Procter & Gamble Company (The) $PG Shares Sold by Ninety One North America Inc."  This indicates that some large investors have decreased their positions in the stock.

**Analysis:** The news paints a mixed picture. Analyst support (Cramer) is a positive, but the headline about a 2-year low and an institutional sell-off are concerns. Sentiment seems to be cautiously optimistic in some circles, but with underlying challenges.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~1.92 on a 1-5 scale)
*   **Target Price (avg/high/low):** 168.95 / 186.00 / 148.00
*   **Recent Rating Changes:** None explicitly mentioned, needs additional data.

**Analysis:** The analyst consensus is a "Buy," indicating a generally positive outlook. The average target price of $168.95 represents a significant potential upside from the current price of $143.31.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-10-24 | 2.00 | 22.39 B$    |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2025-10-24 | 1.65 | 21.74 B$    |

**Analysis:** Revenue has fluctuated slightly over the past few quarters, ranging from 19.78B$ to 22.39B$. The most recent quarter (2025-10-24) showed the highest revenue.
**6) Financial Information**

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $22.39B | 51.37% |
| 2025-06-30 | $20.89B | 49.11% |
| 2025-03-31 | $19.78B | 50.98% |
| 2024-12-31 | $21.88B | 52.39% |
| 2024-09-30 | $21.74B | 52.06% |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $53.27B | 8.92% |
| 2025-06-30 | $52.01B | 6.95% |
| 2025-03-31 | $52.27B | 7.21% |
| 2024-12-31 | $51.17B | 9.05% |
| 2024-09-30 | $51.84B | 7.64% |

**Analysis:** PG maintains consistently high profit margins, generally around 50-52%. The equity has been steadily increasing. ROE fluctuates, with the highest value in Q4 2024.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** PG has significantly underperformed the S&P 500, and this divergence is near its historical worst.
*   **Recent Weakness:** The stock is trading below key moving averages, suggesting short-term bearish momentum.
*   **Mixed Signals:** Technical indicators are neutral. The MRI suggests a favorable investment environment, but the expected return is essentially flat.
*   **Analyst Optimism:** Analyst consensus leans towards a "Buy," with a significant upside potential implied by target prices.
*   **News & Events:** A mixed bag of news; positive analyst sentiment is offset by reports of a 2-year low and institutional selling.
*   **Solid Fundamentals:** P&G boasts consistently high profit margins, and relatively stable revenue and equity.
*   **Recommendation:** Given the underperformance, negative news, and mixed signals, a **cautious approach** is warranted. The analyst "Buy" rating and solid fundamentals suggest potential, but the underperformance relative to the market is a major concern. Any investment should be considered with a long-term horizon, patience, and careful monitoring of future performance. It's important to acknowledge the short-term upswing in relative divergence, but a complete market recovery isn't expected.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.